Active ingredientHalobetasolCat. No. P-H002-001CAS 98651-66-2Family · Pharmaceutical analytical standards
Halobetasol
A super-high-potency topical corticosteroid, patented in 1975 and approved in the United States in 1990 for psoriasis and other steroid-responsive skin conditions. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its international non-proprietary name (INN) is ulobetasol, while halobetasol is the name used in the United States. Chemically it is a close relative of clobetasol, with one extra fluorine atom.
Go to the active ingredient →Active ingredientHalobetasolCat. No. P-H002-001CAS 98651-66-2
Active ingredientHalobetasol DipropionateCat. No. P-H002-002CAS 886204-51-9
Active ingredientHalobetasol PropionateCat. No. P-H002-003CAS 66852-54-8
Isotopically labelledHalobetasol Propionate-d5Cat. No. P-H002-004
Isotopically labelledHalobetasol-d3Cat. No. P-H002-005
Isotopically labelledHalobetasol-d3 PropionateCat. No. P-H002-006
Impurity11-Propionate 21-chloro diflorasoneCat. No. P-H002-007CAS 181527-42-4
Impurity21-Acetate 17-propionate diflorasoneCat. No. P-H002-008CAS 79861-38-4
Impurity9-Chloro halobetasol propionateCat. No. P-H002-009CAS 66852-61-7
ImpurityHalobetasol Impurity 1Cat. No. P-H002-013
ImpurityHalobetasol Impurity 2Cat. No. P-H002-014
ImpurityHalobetasol Impurity 3Cat. No. P-H002-016
ImpurityHalobetasol Impurity 4Cat. No. P-H002-017
ImpurityHalobetasol Impurity 5Cat. No. P-H002-018
ImpurityHalobetasol Propionate Impurity ECat. No. P-H002-019
ImpurityHalobetasol Spiro AnalogCat. No. P-H002-020CAS 912360-04-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.